cantuzumab
milatuzumab
pertuzumab
antinucleotide
scintimammography
farletuzumab
labetuzumab
patritumab
mammothermography
igovomab
oncoimmunotherapy
arcitumomab
tasonermin
adenoma
cedelizumab
votumumab
neoplastic cell
mosunetuzumab
teprotumumab
immunotherapy
pancytokeratin
antithyroglobulin
siltuximab
cancer cell
robatumumab
-tum-
immunocytokine
cergutuzumab
tisotumab vedotin
soravtansine
cytotoxic reaction
immunoblastoma
boob cancer
citatuzumab bogatox
iratumumab
apolizumab
amivantamab
perimammary
olendalizumab
agonistic monoclonal antibody
oregovomab
malignin
etaracizumab
immunocytoma
oophoroma
immunobinding
intrabody
amazia
antisynthetase